| Dr Andrew Michael Servinsky, OD | |
|
1410 Forest Dr, Suite 1, Annapolis, MD 21403-1472 | |
| (410) 295-3010 | |
| (410) 295-3015 |
| Full Name | Dr Andrew Michael Servinsky |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 20 Years |
| Location | 1410 Forest Dr, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962495705 | NPI | - | NPPES |
| 004677900 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TA1897 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Joanne Brilliant O.d., P.a. | 7911976725 | 3 |
News Archive
The Food and Drug Administration approved Vitrase (hyaluronidase for injection). Vitrase is an injectable drug approved as an adjunct to (in combination with) other injected drugs to increase their absorption and dispersion. Hyaluronidase has been used most commonly in combination with local anesthetics in the setting of ophthalmic (eye) surgery.
Registered nurses in hospitals often lack the time for nursing care activities, such as comfort or talk with patients or educating patients and relatives.
Ferring Pharmaceuticals announced today the European launch of CORTIMENT®MMX® (budesonide), the first and only approved oral controlled release budesonide treatment for active mild-to-moderate ulcerative colitis (UC) where mesalazine (5-ASA) treatment is not sufficient.
Arrowhead Research Corporation, a targeted therapeutics company, today announced that its hepatitis B virus (HBV) program has completed all internal preclinical requirements and has named a clinical candidate.
Severe, rapid memory loss may be linked to - and could predict - a future deadly stroke, according to research presented at the American Stroke Association's International Stroke Conference 2012.
› Verified 1 days ago
| Provider Name | Joanne Brilliant O.d., P.a. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1144403098 PECOS PAC ID: 7911976725 Enrollment ID: O20040929000069 |
News Archive
The Food and Drug Administration approved Vitrase (hyaluronidase for injection). Vitrase is an injectable drug approved as an adjunct to (in combination with) other injected drugs to increase their absorption and dispersion. Hyaluronidase has been used most commonly in combination with local anesthetics in the setting of ophthalmic (eye) surgery.
Registered nurses in hospitals often lack the time for nursing care activities, such as comfort or talk with patients or educating patients and relatives.
Ferring Pharmaceuticals announced today the European launch of CORTIMENT®MMX® (budesonide), the first and only approved oral controlled release budesonide treatment for active mild-to-moderate ulcerative colitis (UC) where mesalazine (5-ASA) treatment is not sufficient.
Arrowhead Research Corporation, a targeted therapeutics company, today announced that its hepatitis B virus (HBV) program has completed all internal preclinical requirements and has named a clinical candidate.
Severe, rapid memory loss may be linked to - and could predict - a future deadly stroke, according to research presented at the American Stroke Association's International Stroke Conference 2012.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Michael Servinsky, OD 1410 Forest Dr, Suite 1, Annapolis, MD 21403-1472 Ph: (410) 295-3010 | Dr Andrew Michael Servinsky, OD 1410 Forest Dr, Suite 1, Annapolis, MD 21403-1472 Ph: (410) 295-3010 |
News Archive
The Food and Drug Administration approved Vitrase (hyaluronidase for injection). Vitrase is an injectable drug approved as an adjunct to (in combination with) other injected drugs to increase their absorption and dispersion. Hyaluronidase has been used most commonly in combination with local anesthetics in the setting of ophthalmic (eye) surgery.
Registered nurses in hospitals often lack the time for nursing care activities, such as comfort or talk with patients or educating patients and relatives.
Ferring Pharmaceuticals announced today the European launch of CORTIMENT®MMX® (budesonide), the first and only approved oral controlled release budesonide treatment for active mild-to-moderate ulcerative colitis (UC) where mesalazine (5-ASA) treatment is not sufficient.
Arrowhead Research Corporation, a targeted therapeutics company, today announced that its hepatitis B virus (HBV) program has completed all internal preclinical requirements and has named a clinical candidate.
Severe, rapid memory loss may be linked to - and could predict - a future deadly stroke, according to research presented at the American Stroke Association's International Stroke Conference 2012.
› Verified 1 days ago
Dr. Ryan Shaun Sullivan, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2321 Forest Dr, Annapolis, MD 21401 Phone: 410-266-3369 | |
Jonathan Jacesko, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 695 Kinkaid Rd, Annapolis, MD 21402 Phone: 410-293-3617 | |
Dr. David A Byman, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 695 Kinkaid Rd, Annapolis, MD 21402 Phone: 410-293-3617 | |
Dr. Elizabeth C Mcmunn, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 695 Kinkaid Rd, Annapolis, MD 21402 Phone: 410-293-4378 | |
Dr. Jay Thompson Rorick, MD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 888 Bestgate Road, Suite 102, Annapolis, MD 21401 Phone: 410-571-7325 Fax: 410-571-7301 | |
Wenny Tan, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1505 Annapolis Mall, Annapolis, MD 21401 Phone: 410-573-2095 | |
Anchor Eyecare Annapolis Optometrist Medicare: Not Enrolled in Medicare Practice Location: 321 Kinkaid Rd, Building 329, Annapolis, MD 21402 Phone: 410-757-8169 Fax: 410-349-0079 |